A detailed history of Candriam S.C.A. transactions in Boston Scientific Corp stock. As of the latest transaction made, Candriam S.C.A. holds 474,915 shares of BSX stock, worth $41.6 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
474,915
Previous 436,741 8.74%
Holding current value
$41.6 Million
Previous $33.6 Million 18.33%
% of portfolio
0.23%
Previous 0.21%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $2.79 Million - $3.21 Million
38,174 Added 8.74%
474,915 $39.8 Million
Q2 2024

Aug 05, 2024

BUY
$67.33 - $77.71 $924,440 - $1.07 Million
13,730 Added 3.25%
436,741 $33.6 Million
Q1 2024

May 03, 2024

SELL
$57.6 - $68.62 $3.71 Million - $4.43 Million
-64,488 Reduced 13.23%
423,011 $29 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $2.1 Million - $2.5 Million
43,268 Added 9.74%
487,499 $28.2 Million
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $5.28 Million - $5.75 Million
105,227 Added 31.04%
444,231 $23.5 Million
Q2 2023

Aug 08, 2023

SELL
$49.72 - $54.64 $3.67 Million - $4.03 Million
-73,721 Reduced 17.86%
339,004 $18.3 Million
Q1 2023

May 12, 2023

BUY
$45.09 - $50.03 $759,631 - $842,855
16,847 Added 4.26%
412,725 $20.6 Million
Q4 2022

Feb 13, 2023

SELL
$39.56 - $47.22 $1.72 Million - $2.05 Million
-43,458 Reduced 9.89%
395,878 $18.3 Million
Q3 2022

Nov 10, 2022

BUY
$36.71 - $109.66 $7.97 Million - $23.8 Million
217,121 Added 97.71%
439,336 $17 Million
Q2 2022

Aug 03, 2022

BUY
$35.24 - $47.1 $5.16 Million - $6.89 Million
146,361 Added 192.95%
222,215 $8.28 Million
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $60,654 - $66,883
1,483 Added 1.99%
75,854 $3.36 Million
Q4 2021

Feb 10, 2022

SELL
$38.07 - $44.87 $335,815 - $395,798
-8,821 Reduced 10.6%
74,371 $3.16 Million
Q3 2021

Nov 09, 2021

BUY
$41.23 - $45.88 $3,092 - $3,441
75 Added 0.09%
83,192 $3.61 Million
Q2 2021

Jul 20, 2021

SELL
$38.58 - $44.24 $124,073 - $142,275
-3,216 Reduced 3.73%
83,117 $3.55 Million
Q4 2020

Jan 22, 2021

BUY
$33.15 - $41.97 $369,058 - $467,252
11,133 Added 14.8%
86,333 $3.1 Million
Q3 2020

Oct 19, 2020

SELL
$34.44 - $42.23 $208,947 - $256,209
-6,067 Reduced 7.47%
75,200 $2.87 Million
Q2 2020

Jul 23, 2020

SELL
$30.19 - $39.11 $612,434 - $793,385
-20,286 Reduced 19.98%
81,267 $2.85 Million
Q4 2019

Jan 21, 2020

SELL
$37.87 - $45.37 $206,921 - $247,901
-5,464 Reduced 5.11%
101,553 $5,000
Q3 2019

Oct 21, 2019

BUY
$40.31 - $43.45 $111,860 - $120,573
2,775 Added 2.66%
107,017 $4,000
Q2 2019

Aug 01, 2019

SELL
$34.91 - $42.98 $204,258 - $251,475
-5,851 Reduced 5.31%
104,242 $4.46 Million
Q1 2019

May 02, 2019

BUY
$32.91 - $40.75 $128,316 - $158,884
3,899 Added 3.67%
110,093 $4.23 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $88,558 - $108,960
-2,791 Reduced 2.56%
106,194 $3.75 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $137,742 - $176,130
5,132 Added 4.94%
108,985 $3.56 Million
Q4 2017

Feb 07, 2018

SELL
$24.79 - $29.8 $89,566 - $107,667
-3,613 Reduced 3.36%
103,853 $2.58 Million
Q3 2017

Nov 03, 2017

BUY
$26.26 - $29.17 $2.82 Million - $3.13 Million
107,466
107,466 $3.14 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.